Search Results - "Atignal, A"

dose range finding study of novel oral insulin (IN-105) under fed conditions in type 2 diabetes mellitus subjects by Khedkar, A, Iyer, H, Anand, A, Verma, M, Krishnamurthy, S, Savale, S, Atignal, A

“…Aim: The objective of the study was to establish the dose response of IN-105 tablets and explore a possible therapeutic window in type 2 diabetes subjects…”
Get full text

Basalog® is similar to Lantus® in producing glycemic control in patients with type 1 diabetes mellitus on multiple daily insulin regimens by Verma, M., Hazra, P., Iyer, H., Arun, A., Akundi, S., Dixit, M. N., Eswaraiah, A., Prasanna, C. G., Atignal, A.

“…This study was performed to compare the insulin glargine produced by two different manufacturers. The study determines the efficacy and safety of a new insulin…”
Get full text

Pharmacokinetics and pharmacodynamics of a single oral dose of the insulin analog IN-105, in tablet form, in normal healthy volunteers, in the presence of food by Suryanarayan, S, Khedkar, A, Vedala, A, Iyer, H, Anil, K, Desai, S, Savale, S, Atignal, A

Get full text